These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9845923)

  • 1. [Antithrombotic effect of catalase and chondroitin sulfate derivatives in arterial damage in rats].
    Maksimenko AV; Tishchenko EG; Golybykh VL
    Vopr Med Khim; 1998; 44(4):362-8. PubMed ID: 9845923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antithrombotic activity of complexes of superoxide dismutase with chondroitin sulfate in arterial damage in rats].
    Maksimenko AV; Tishchenko EG; Golubykh VL
    Vopr Med Khim; 1998; 44(4):353-61. PubMed ID: 9845922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic activity of the superoxide dismutase-chondroitin sulfate complexes in a rat model of arterial injury.
    Maksimenko AV; Tischenko EG; Golubykh VL
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):479-84. PubMed ID: 10686656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalase and chondroitin sulfate derivatives against thrombotic effect induced by reactive oxygen species in a rat artery.
    Maksimenko AV; Golubykh VL; Tischenko EG
    Metab Eng; 2003 Jul; 5(3):177-82. PubMed ID: 12948751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
    Fonseca RJ; Santos GR; Mourão PA
    Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of superoxide dismutase and catalase.
    Maksimenko AV
    Curr Pharm Des; 2005; 11(16):2007-16. PubMed ID: 15974955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of modified antioxidant enzymes for anti-thrombotic protection of the vascular wall: the significance of covalent connection of superoxide dismutase and catalase activities.
    Maksimenko AV; Golubykh VL; Tischenko EG
    J Pharm Pharmacol; 2004 Nov; 56(11):1463-8. PubMed ID: 15525455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
    Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
    Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective action figurations for superoxide dismutase - chondroitin sulfate - catalase bienzyme conjugate after its medicative administration in endotoxin shock].
    Maksimenko AV; Vavaeva AV; Zvyagintseva MA; Abramov AA; Timoshin AA; Vavaev AV; Lakomkin VL
    Biomed Khim; 2016 Mar; 62(3):295-301. PubMed ID: 27420622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
    Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
    Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic profile of sulfamino-galactosaminoglycans.
    Pescador R; Porta R; Mantovani M; Prino G; Casu B; Naggi A; Torri G; Walenga JM; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 1():74-9. PubMed ID: 1906197
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase.
    Wu M; Wen D; Gao N; Xiao C; Yang L; Xu L; Lian W; Peng W; Jiang J; Zhao J
    Eur J Med Chem; 2015 Mar; 92():257-69. PubMed ID: 25559206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of chondroitin sulfate as a therapeutic agent.
    Lamari FN
    Connect Tissue Res; 2008; 49(3):289-92. PubMed ID: 18661362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic activity of a fucosylated chondroitin sulphate from echinoderm: sulphated fucose branches on the polysaccharide account for its antithrombotic action.
    Mourão PA; Giumarães B; Mulloy B; Thomas S; Gray E
    Br J Haematol; 1998 Jun; 101(4):647-52. PubMed ID: 9674735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
    Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifibrosis effect of modified forms of catalase and superoxide dismutase in experimental silicosis].
    Maksimenko AV; Bezrukavnikova LM; Grigor'eva EL; Tishchenko EG; Arkhipova OG; Iaglov VV; Torchilin VP
    Vopr Med Khim; 1992; 38(3):4-8. PubMed ID: 1384235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic activities of fucosylated chondroitin sulfates and their depolymerized fragments from two sea cucumbers.
    Liu X; Hao J; Shan X; Zhang X; Zhao X; Li Q; Wang X; Cai C; Li G; Yu G
    Carbohydr Polym; 2016 Nov; 152():343-350. PubMed ID: 27516281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of catalase by chondroitin sulfate.
    Maksimenko AV; Tischenko EG
    Biochemistry (Mosc); 1997 Oct; 62(10):1167-70. PubMed ID: 9461640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects.
    Nakazawa K; Murata K
    Z Alternsforsch; 1979; 34(2):153-9. PubMed ID: 395771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.